Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-027328

SVP, Chief Accounting Officer acquired 1,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Huizenga Theodore Alan · SVP, Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-04-16 Grant or award : show line 1 in the form +1,500 15,044 D
Loading xslF345X03/doc4.xml…